Is Vilon FDA approved?
No. This profile records Vilon as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
Healing CATEGORY
Vilon
THE LONGEVITY DIPEPTIDE
Lys-Glu, KE Dipeptide, Immunomodulatory Peptide
Vilon is a synthetic dipeptide (lysine-glutamic acid) that enhances immune function while reducing signs of aging. It works by balancing cytokines, promoting tissue repair, and activating longevity genes. Despite its simple structure, it has powerful effects on immune coordination and cellular regeneration.
Vilon
Vilon
Vilon
Vilon Evidence Snapshot
How these guides are reviewed
REGULATORY STATUS
Not FDA approved · research use only
DOSING GUIDANCE
Reviewed by our clinical team
LINKED EVIDENCE
1 research sources
CONTENT UPDATED
Aug 28, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
Quick Answers About Vilon
What dose does The Peptide App Clinical Team recommend for Vilon?
Dose: 1 mg subcutaneously 3x per week.
MORE CONTEXT ›
Schedule: daily. Cycle: 3 weeks on, 4 weeks off. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
What research supports this Vilon guide?
This guide links to 1 curated or current research sources.
MORE CONTEXT ›
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Studied Effects & Mechanisms
Immune Modulation
Enhances T- and B-cell activation while balancing cytokine production
Epigenetic Regulation
Influences gene expression via histone acetylation and p53/FOXO pathways
Antioxidant Support
Increases SOD, catalase, and GPx enzymes while supporting telomerase
People with weakened immune function
Anyone recovering from illness or immune challenge
People seeking immune balance without stimulation
Those with accelerated aging concerns
Vilon Research
Live research temporarily unavailableThe live research feed did not return papers for this page. The curated references below remain available for crawlable source context.
RESEARCH REFERENCES